Platform

Monitor. Discover. Analyse.

Continuum watches your existing positions continuously, surfaces new ideas from cross-domain evidence shifts, and delivers structured analysis on any name — with every claim traced to its source.

Three layers, connected for the first time.

Every workflow below is possible because Continuum reads across price, financials, and the full unstructured evidence universe simultaneously.

Each layer is available today. Separately. The signal lives at the intersections.

01

Monitor

Thirty positions. Ten evidence domains each. Hundreds of sources updating daily. Most mornings, the answer is "nothing actionable" — and that's valuable, because it means you focus energy on the names that need attention today instead of anxiously scanning headlines.

When something does matter, Continuum tells you why.

Tripwires Approaching

Pre-committed revision conditions tracked against incoming data. You defined "what would change my mind" before the pressure arrived. Continuum watches for it.

Domain Disagreements

Evidence from one domain contradicts another. Management says one thing, the regulatory filing says another. You see the contradiction, not a summary of it.

Hypothesis Shifts

The evidence balance between competing interpretations has moved. One thesis gaining ground, another losing it. The survival scores update continuously.

Continuous monitoring

Threshold Approaching
AssumptionGross margins remain above 35%
Current statusQ1 margin at 35.2% — approaching threshold
ActionReview thesis assumptions before Q2 results

When the threshold is met, the burden shifts to finding reasons not to update.

What Continuum watches for

Divergence can persist without new data and resolve without it. The platform monitors for conditions under which markets actually update.

Attention shifts

Known information becomes noticed

Frame changes

Same facts, different interpretation

Narrative exhaustion

Good news stops moving the stock

Social proof fracture

A respected voice breaks ranks

Time revelation

Implicit predictions miss their deadline

Reflexivity unwinding

Self-reinforcing loop runs out of believers

Personnel turnover

New analysts see the situation fresh

Adjacent events

Related failure forces the question

02

Discover

Continuum doesn't just watch what you own. It reads across the full evidence universe — and surfaces names where the gap between evidence and price is widening, where cross-domain signals are converging on something the market hasn't priced, where embedded assumptions are most poorly supported.

These aren't screens. They're fundamentally-derived signals from the same evidence engine that monitors your portfolio.

Divergence Detection

The evidence base on a name has shifted materially. The price hasn't moved. The narrative hasn't changed. Something is building that the market hasn't recognised.

Cross-Domain Connections

A filing in one sector reveals something about a company in another. A competitor's revised JORC estimate tells you the adjacent tenement holder is pricing geology that no longer exists. Invisible in single-domain analysis.

Consensus Fragility

Where is the market's confidence most poorly supported by evidence? Which names embed assumptions that multiple independent signals suggest are under pressure?

Thesis Orphans

Well-evidenced hypotheses with no price expression. Under-researched names where the evidence supports a structured view that doesn't exist anywhere in the market.

Ideas surfaced by the evidence engine

Discovery Feed
DIVERGENCEIndustrial Metals

Evidence base shifted materially over 60 days — scrap pricing recovery, China import policy reversal, competitor margin expansion. Stock flat, no analyst revision. Price still embeds the old narrative.

4 domains12 evidence items60-day signal
CROSS-DOMAINLithium Mining

Competitor's revised JORC resource estimate downgrades a specific geological formation. Adjacent tenement holder on the same formation hasn't drilled yet. Market cap still prices the original geology.

3 domains7 evidence items14-day signal
FRAGILITYMajor Bank

Premium multiple leaves no margin for error. Embedded thesis depends on NIM stability, but three independent signals — deposit competition, switching data, regulatory commentary — suggest the assumption is under pressure.

5 domains18 evidence items90-day signal
THESIS ORPHANSpecialty Pharma

Zero active sell-side coverage post-analyst departures. Phase III readout, TGA submission timeline, and licensing deal structure create a well-evidenced base case with no structured view in market.

6 domains23 evidence itemsOngoing

The best ideas often come from evidence that exists in public but hasn't been connected yet. Continuum connects it.

Request AccessSee Continuum applied to your portfolio.
03

Analyse

Pick any name — an existing position flagged by the monitoring layer, a new idea surfaced by the discovery engine, or something your team brought in independently. Continuum delivers the same structured treatment: what the price embeds, what could replace it, what the evidence says.

Cross-domain evidence synthesis

Domain Disagreement Detected
ASX

Corporate disclosure

"Operating at optimal capacity with strong demand visibility"

FY25 Annual Report, p.34

AER

Regulatory filing

Production data implies 67% utilisation rate

Quarterly Energy Report, Table 4.2

ASX

Competitor disclosure

"Industry-wide overcapacity pressuring margins across the sector"

Competitor H1 results transcript

Assessment: Corporate narrative inconsistent with regulatory and competitor evidence. Utilisation gap of ~33% not reflected in market assumptions.

Competing hypotheses, ranked by survival

Hypothesis Survival Assessment
H2Structural decline
HIGH
78%

1 disconfirming item across 12 targeted searches

H1Pricing power intact
MODERATE
62%

2 disconfirming items across 12 targeted searches

H3Turnaround in progress
LOW
31%

4 disconfirming items across 12 targeted searches

Ranking by survival: H2 (Structural decline) > H1 (Pricing power intact) > H3 (Turnaround)

Every claim traced to source

ACCC found concentration levels in grocery retail create conditions where coordinated conduct is more likely.[1]

1

ACCC Supermarket Inquiry Final Report (2025)

Chapter 4 — Market Structure Analysis, Page 47

Open source document View in context

Narrative Intelligence

For well-covered securities

Multiple analysts cover the stock. The opportunity is understanding what's embedded in the collective view and finding evidence from domains nobody routinely synthesises.

Embedded thesis extraction
Competing hypotheses with survival scoring
Cross-domain evidence mapping
Revision conditions and monitoring

Primary Analysis

For under-researched securities

No analyst covers the stock. The opportunity is comprehensive synthesis — reading everything relevant and applying disciplined method to generate a well-founded view.

Fundamental assessment with domain frameworks
Technical evaluation (JORC, clinical, engineering)
Competing scenarios with required assumptions
Risk map and execution analysis

Monitor. Discover. Analyse. Continuously.

See how Continuum applies unified analysis to a real portfolio.

Continuum is in private access with select institutional investors.